SEP 02, 2020 9:54 AM PDT

Alarmins: The Immune "Gold" in Breast Milk

WRITTEN BY: Tara Fernandez

We know that infants fed with breast milk develop more robust immune systems as a result of factors that support the natural intestinal flora. Just what these factors are and how they exert their immune-boosting effects have, however, eluded scientists until now.

Scientists from the Hannover Medical School have finally uncovered the secret weapon against pathogenic bacteria within breast milk: proteins called alarmins. "Alarmins are the 'gold' in breast milk. These proteins prevent dangerous intestinal colonization disorders that can lead to blood poisoning and intestinal inflammation," explains Dorothee Viemann, who led the research study published in the medical journal Gastroenterology.

After birth, the intestinal immune system matures through encounters with various bacteria present in the environment. This gives babies life-long protection against a range of infections. Alarmins are central players in this adaptation process. These proteins are known to be involved in a diverse range of physiological and pathophysiological processes including wound healing, inflammation, cancer development, and allergies. Besides breast milk, babies also pick up alarmins from their mothers through natural births. Interestingly, individuals born via C-section are more prone to developing chronic inflammatory diseases later in life.

This discovery is the first step in developing clinical interventions to support children without access to breast milk. "Supplementation with these proteins could support the development of newborns which do not produce enough alarmins or get enough in breast milk,” says Viemann. “That could prevent a range of long-term conditions linked to intestinal colonization disorders, such as chronic intestinal inflammation and obesity."

Experiments using mouse models revealed that a single dose of alarmins provided the animals with the development of a more robust gut microbiome and resistance against inflammatory diseases. The team plans to further their research through advanced preclinical studies as well as follow-up clinical trials.
 

Sources: Gastroenterology, Science Daily.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
APR 20, 2021
Immunology
Scientists Map the Genetic Landscape of COVID Infections
APR 20, 2021
Scientists Map the Genetic Landscape of COVID Infections
Scientists have identified 65 human immune genes activated during SARS-CoV-2 infection. This finding provides valuable i ...
APR 22, 2021
Immunology
Healthy, Young People Are Getting Reinfected With COVID
APR 22, 2021
Healthy, Young People Are Getting Reinfected With COVID
If you’re young and healthy and you’ve had COVID, your body will produce protective antibodies that guard yo ...
MAY 04, 2021
Immunology
One Vaccine to Rule Them All
MAY 04, 2021
One Vaccine to Rule Them All
There are currently five variants of concern in the U.S., genetically distinct forms of the COVID-causing coronavirus th ...
JUN 11, 2021
Cell & Molecular Biology
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
JUN 11, 2021
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
The immune system can detect and destroy pathogenic and cancerous cells, but sometimes those dangerous cells can evade t ...
JUN 29, 2021
Immunology
The Heartbreaking Nature of COVID Revealed
JUN 29, 2021
The Heartbreaking Nature of COVID Revealed
Researchers at the Washington University School are getting to the root of heart damage resulting from COVID-19 infectio ...
JUL 27, 2021
Cell & Molecular Biology
Nanobodies May Prevent Complications From Infection in Transplant Recipents
JUL 27, 2021
Nanobodies May Prevent Complications From Infection in Transplant Recipents
In recent years, scientists java turned their attention to small antibodies that are produced by animals like sharks, ca ...
Loading Comments...